Phase Genomics Inc.
Seattle, WA
- UEI
- TQ67ST6YELX5
- CAGE
- 7BWU2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1617 8th Ave N, Seattle, WA 98109, USA
- Website
- phasegenomics.com
- Founded
- 2015
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $35,550 |
| FY2023 | $9,520 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Phase Genomics Inc. is a biotechnology company based in Seattle, Washington, specializing in advanced genomic sequencing and analysis services. The company focuses on providing sophisticated genomic solutions utilizing proximity ligation techniques, particularly Hi-C technology, which enables high-resolution genome assembly and structural variation analysis. Their services primarily target federal agencies across multiple scientific domains, including agricultural research, marine biology, infectious disease research, and genetic diagnostics.
Through federal contract awards, Phase Genomics has consistently provided specialized genomic sequencing services to various federal agencies. These contracts, predominantly set aside for small businesses, have included next-generation sequencing projects for agencies like the National Oceanic and Atmospheric Administration (NOAA) and the U.S. Department of Agriculture's Agricultural Research Service. Specific contract work has encompassed genome sequencing for marine species like sea scallops and rainbow trout, plant species genomics for fescue and penstemon, and microbiome-related research involving fecal sample analysis. The contract values have ranged from approximately $4,999 to $46,500, demonstrating the company's ability to execute precise, targeted genomic research projects across different biological systems.
Phase Genomics has secured multiple significant federal grants, primarily from institutes like the National Institute of Allergy and Infectious Diseases, National Cancer Institute, and National Human Genome Research Institute. These grants have focused on cutting-edge research areas such as developing novel antimicrobial approaches using mRNA technology, creating advanced cytogenomic diagnostic methods for cancer research, and developing computational platforms for discovering viral genomes and identifying their hosts. The grant work has emphasized innovative approaches like proximity ligation sequencing, machine learning-based host-range prediction for bacteriophages, and developing diagnostic technologies for chromosomal aberration detection. Grant values have ranged from approximately $14,250 to $299,163, reflecting the company's capability to conduct sophisticated, forward-looking research with potential significant medical and scientific implications.
Quick answers
Is Phase Genomics Inc. registered in SAM.gov?
Yes. Phase Genomics Inc.'s SAM.gov registration is active through October 14, 2027.
How much has Phase Genomics Inc. received in federal contracts?
Federal contracts obligated $45,070 to Phase Genomics Inc. in fiscal years 2023 through 2027.
What is Phase Genomics Inc.'s most recent federal award?
Phase Genomics Inc.'s most recent federal grant award is Harnessing mrna vaccine technology for precision antimicrobial delivery (R43AI192163), from National Institute of Allergy and Infectious Diseases (NIH), on April 22, 2025.
On GovTribe
See Phase Genomics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors